Skip to main content
. 2014 Oct 28;20(40):14875–14883. doi: 10.3748/wjg.v20.i40.14875

Table 2.

Comparison of levels of hyaluronic acid, hydroxyproline and transforming growth factor β1 in liver homogenates

Group n HA (ng/g) Hyp (μg/g) TGF-β1 (μg/g)
A 15 1449.93 ± 121.89 318.20 ± 9.71 284.20 ± 18.32
B 13 8803.30 ± 200.57b 617.77 ± 8.52b 736.30 ± 24.40b
C 15 7558.40 ± 161.88bd 530.27 ± 11.88bd 651.13 ± 15.75bd
D 14 5249.21 ± 111.92bdf 490.00 ± 8.13bdf 523.14 ± 21.29bdf
E 15 4050.73 ± 122.18bdfh 464.07 ± 13.09bdfh 441.86 ± 23.18bdfh

Data are expressed as mean ± SD. A: Normal group; B: Model group; C: Natural recovery group; D: Low dose Danshao Huaxian capsule (DHC) treated group; E: High dose DHC treated group.

b

P < 0.01 vs group A;

d

P < 0.01 vs group B;

f

P < 0.01 vs group C;

h

P < 0.01 vs group D.

HHS Vulnerability Disclosure